Occupational Asthma and Its Causation in the UK Seafood Processing Industry.

allergens asthma incidence rate asthmagens fish occupational asthma parvalbumin seafood processing shellfish tropomyosin

Journal

Annals of work exposures and health
ISSN: 2398-7316
Titre abrégé: Ann Work Expo Health
Pays: England
ID NLM: 101698454

Informations de publication

Date de publication:
08 10 2020
Historique:
received: 23 09 2019
revised: 23 04 2020
accepted: 13 05 2020
pubmed: 4 6 2020
medline: 10 2 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

The processing of seafood (fish and shellfish) for human consumption can lead to health consequences, including occupational asthma (OA). Several non-UK studies have reported both respiratory outcomes and airborne levels of major allergens in seafood processing. However, there is a paucity of such evidence in the UK land-based seafood processing sector, which employs some 20 000 workers. University of Manchester's Surveillance of Work-related and Occupational Respiratory Disease (SWORD) reporting system has been interrogated over the period 1992-2017 to define the incidence rate of OA cases that can be ascribed to the UK land-based processing sector, and the seafood species implicated. Airborne allergen monitoring data undertaken at Health and Safety Executive's laboratory from 2003 to 2019 have also been collated. The estimated annual OA incidence rate in seafood processors was 70 [95% confidence intervals (CIs) 48.9, 91.1] per 100 000 workers compared with 2.9 (95% CIs 2.8, 3.1) in 'all other industries'. The annual calculated percentage trend in OA (1992-2017) was -8.1% (95% CIs -15.9, 0.4) in seafood processing showing a similar trend to 'all other industries' (mean -7.0%; 95% CIs -7.8, -6.1). Prawns and salmon/trout were notably implicated by SWORD as causative species related to OA. There is a general paucity of available UK airborne allergen monitoring data, particularly concerning processing salmon or trout. Available airborne monitoring for salmon parvalbumin in seven processors ranged between the limit of detection and 816 ng m-3 (n = 64). Available air monitoring levels of the major shellfish allergen (tropomyosin) during processing of crabs and prawns ranged between 1 and 101 600 ng m-3 (n = 280), highlighting that high levels of exposure can occur. These data show an excess incidence of OA in the UK seafood processing industry during 1992-2017, with limited airborne monitoring data for the processing of prawn, crab, and salmon suggesting that significant exposure to major seafood allergens can occur in this industry. Further investigation of current levels of respiratory ill-health and the sources of allergen exposure are warranted.

Identifiants

pubmed: 32491156
pii: 5850842
doi: 10.1093/annweh/wxaa055
pmc: PMC7543999
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

817-825

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.

Références

Occup Environ Med. 2008 Dec;65(12):808-14
pubmed: 18417553
Curr Allergy Asthma Rep. 2013 Jun;13(3):288-97
pubmed: 23575656
Lancet. 1995 Sep 16;346(8977):737-40
pubmed: 7658875
Occup Environ Med. 2010 Jan;67(1):17-23
pubmed: 19736174
Curr Opin Allergy Clin Immunol. 2010 Apr;10(2):104-13
pubmed: 20179585
Occup Med (Lond). 2006 Jan;56(1):63-6
pubmed: 16380400
Adv Food Nutr Res. 2012;66:47-73
pubmed: 22909978
Am J Ind Med. 2012 Jul;55(7):624-30
pubmed: 22576678
Occup Med (Lond). 2008 May;58(3):169-74
pubmed: 18308695
Clin Exp Allergy. 2010 Jun;40(6):850-8
pubmed: 20412131
Am J Ind Med. 2008 Dec;51(12):899-910
pubmed: 18726880
Lancet. 1980 Dec 20-27;2(8208-8209):1350-3
pubmed: 6109164
N Engl J Med. 2014 Feb 13;370(7):640-9
pubmed: 24521110
Allergy Rhinol (Providence). 2012 Fall;3(2):e74-90
pubmed: 23342293
Occup Environ Med. 2001 Sep;58(9):553-62
pubmed: 11511741
Occup Med (Lond). 2011 Jan;61(1):33-9
pubmed: 21059739
Occup Environ Med. 2019 Jun;76(6):396-397
pubmed: 30936407
Clin Exp Immunol. 1994 Sep;97(3):499-504
pubmed: 8082306
Occup Med (Lond). 2008 Dec;58(8):545-50
pubmed: 18832347
Saf Health Work. 2017 Sep;8(3):231-236
pubmed: 28951798
Br J Ind Med. 1991 May;48(5):292-8
pubmed: 2039741
Allergy. 2010 Feb;65(2):191-8
pubmed: 19796207

Auteurs

Howard J Mason (HJ)

Health and Safety Executive Science and Research Centre, Biohazards Team, Harpur Hill, Buxton, UK.

Melanie Carder (M)

Centre for Occupational and Environmental Health, University of Manchester, Manchester, UK.

Annemarie Money (A)

Centre for Occupational and Environmental Health, University of Manchester, Manchester, UK.

Gareth Evans (G)

Health and Safety Executive Science and Research Centre, Biohazards Team, Harpur Hill, Buxton, UK.

Martin Seed (M)

Centre for Occupational and Environmental Health, University of Manchester, Manchester, UK.

Raymond Agius (R)

Centre for Occupational and Environmental Health, University of Manchester, Manchester, UK.

Martie van Tongeren (M)

Centre for Occupational and Environmental Health, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH